Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
1.8
Journals
Pharmacy
Special Issues
Pharmacy Practice for Women’s/Reproductive Health
share announcement

Pharmacy Practice for Women’s/Reproductive Health

A special issue of Pharmacy (ISSN 2226-4787).

Deadline for manuscript submissions: 30 April 2026 | Viewed by 2332

Special Issue Editor

Dr. Nicole Cieri-Hutcherson

E-Mail Website
Guest Editor
Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14214, USA
Interests: women’s health; contraception; infertility; pregnancy; lactation; breastfeeding; menopause; hormone therapy; menstruation; vaginal disorders; sickle cell disease

Special Issue Information

Dear Colleagues,

The role of pharmacists, pharmacies, and healthcare institutions in the delivery of reproductive healthcare and is rapidly expanding. In addition, the evolving legislative landscape is increasingly important to navigate to deliver high-quality care.

We invite you to share your views and research by submitting a manuscript to the “Pharmacy Practice for Women’s/Reproductive Health” Special Issue in the journal Pharmacy—an open-access journal with a focus on pharmacy education and practice.

For this Special Issue, we seek manuscripts including, but not limited to the following topics related to pharmacists and reproductive health: (1) training and education, (2) implementation, (3) payment for services, (4) clinical outcomes, (5) public awareness, and (6) policy. We seek manuscripts of all types including: (1) reviews, (2) commentaries, (3) idea papers, (4) case studies, (5) demonstration studies, and (6) research studies.

I hope this Special Issue will inspire pharmacists, policymakers, advocates, and researchers to expand the pharmacist’s role in reproductive healthcare across the lifespan.

Please feel free to contact me with any ideas or questions. I look forward to your submissions.

Dr. Nicole Cieri-Hutcherson
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pharmacist
  • pharmacy
  • reproductive health
  • women’s health
  • contraceptive care
  • obstetrics
  • menopause
  • gynecology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (3 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

19 pages, 619 KB  
Article
Factors, Attitudes, and Prevalence of Self-Medication Among Pregnant Women: A Cross-Sectional Study in Saudi Arabia
by Alla Alhumaid, Noha Alhumaid, Khalid Alkhurayji, Abdallah Alsuhaimi, Fawaz Modahi, Noor Almanidi, Abdullah Almutairi, Abdullah Alanazi and Nayif Modahi
Pharmacy 2025, 13(5), 138; https://doi.org/10.3390/pharmacy13050138 - 1 Oct 2025
Viewed by 409
Abstract
Background: Self-medication (SM) among women during pregnancy poses a critical risk to maternal health, and SM is still commonly practiced in Saudi Arabia. Therefore, this study aims to assess the factors, attitudes, and prevalence of SM among pregnant women in the Ministry of [...] Read more.
Background: Self-medication (SM) among women during pregnancy poses a critical risk to maternal health, and SM is still commonly practiced in Saudi Arabia. Therefore, this study aims to assess the factors, attitudes, and prevalence of SM among pregnant women in the Ministry of Health (MOH) First Health Cluster. Methods: A cross-sectional design was used among 400 pregnant women who received care at primary, secondary, and tertiary healthcare levels. A structured tool was adopted and modified based on the literature review, expert and focus group interviews, and the experiences of the target participants. The dependent variables included history of illness, access to healthcare services, medication usage, and perception of SM, while the independent variables included socioeconomic status. Statistical Package for the Social Sciences (SPSS), Version 25 was used for analysis. Results: The prevalence of SM was 36.5%. Cough syrup and antipyretics were the most commonly used medications, while hair problems and weight loss were the most frequently reported reasons for SM. The primary sources of information guiding SM behavior were prior prescriptions and previous experience. Education level, occupation, age, number of pregnancies, and miscarriage history were all significantly associated with SM (p < 0.05). Conclusions: SM was found to be frequent among pregnant women in the First Health Cluster, highlighting the need for educational interventions and regulatory measures to reduce unsafe practices and improve maternal health. Full article
(This article belongs to the Special Issue Pharmacy Practice for Women’s/Reproductive Health)
►▼ Show Figures

Figure 1

15 pages, 218 KB  
Article
Pharmacist Dispensing of Mifepristone: Evaluation of Knowledge and Support Before and After a Continuing Education Course
by Natalie Morris, Alexa Orosz, M. Antonia Biggs, Sally Rafie and Daniel Grossman
Pharmacy 2025, 13(5), 131; https://doi.org/10.3390/pharmacy13050131 - 15 Sep 2025
Viewed by 550
Abstract
Medication abortion with mifepristone and misoprostol is a safe and effective method for ending a pregnancy. Pharmacy dispensing of mifepristone was approved by the U.S. Food and Drug Administration in 2023, but educational opportunities for pharmacists were nonexistent. We designed a 1 h [...] Read more.
Medication abortion with mifepristone and misoprostol is a safe and effective method for ending a pregnancy. Pharmacy dispensing of mifepristone was approved by the U.S. Food and Drug Administration in 2023, but educational opportunities for pharmacists were nonexistent. We designed a 1 h continuing education course on medication abortion for pharmacists, which was offered in a live-webinar or recorded-video format over 3 years. It included key medication abortion topics, including medications, patient counseling, relevant policies, and implementing pharmacy dispensing. Using a prepost design, we administered online surveys to participants prior to and after completing the course to assess changes in overall medication abortion knowledge score (six items, Cronbach’s alpha = 0.76) and support for pharmacist dispensing of medication abortion (one Likert-scaled item). During the study period, 279 students and pharmacists took the course, of which 148 completed both the pre- and post-course questionnaires. Adjusted regression analyses demonstrated significant increases in knowledge scores and support for pharmacist dispensing of medication abortion post-course; most thought dispensing mifepristone would be very (21.6%) or somewhat easy (38.5%) to implement, and 75% indicated a willingness to dispense mifepristone if allowed. These findings suggest that video-based education on medication abortion is an effective tool for enhancing pharmacists’ knowledge and support for medication abortion, which could increase access to reproductive health care. Full article
(This article belongs to the Special Issue Pharmacy Practice for Women’s/Reproductive Health)
17 pages, 562 KB  
Article
Detection of Problems Related to Hormonal Contraceptives in Community Pharmacy: Application of a Structured Questionnaire in Women of Childbearing Age
by Raquel Sicilia-González, Susana Abdala-Kuri, Chaxiraxi Morales-Marrero, Adama Peña-Vera, Alexis Oliva-Martín and Sandra Dévora-Gutiérrez
Pharmacy 2025, 13(4), 112; https://doi.org/10.3390/pharmacy13040112 - 21 Aug 2025
Viewed by 763
Abstract
The use of hormonal contraceptives is essential to ensure effective and safe contraception. However, factors such as inadequate prescription, poor adherence, or lack of information can lead to drug-related problems (DRPs) and negative outcomes associated with medication (NOMs). Methods: An observational, descriptive, cross-sectional [...] Read more.
The use of hormonal contraceptives is essential to ensure effective and safe contraception. However, factors such as inadequate prescription, poor adherence, or lack of information can lead to drug-related problems (DRPs) and negative outcomes associated with medication (NOMs). Methods: An observational, descriptive, cross-sectional study was conducted between January and June 2024 in two community pharmacies in Tenerife. It included 316 users of hormonal contraceptives over the age of 18. The main instrument was a structured questionnaire, administered through individual interviews conducted in the Personalized Care Area (PCA). Results: Combined Oral Contraceptives (COCs) were the most frequently used method (72.2%). Adverse reactions were reported by 47.2% of participants, mainly psychiatric disorders (28.1%). Emergency contraception had been used at least once by 43.8% of the respondents. Among COC users, 68.9% reported difficulties with daily adherence, and only 36.7% had adequate knowledge in case of missed doses. Conclusions: Community pharmacists may play a key role in reproductive health by providing personalized counselling, referring patients to other levels of care, and promoting the rational and safe use of hormonal contraceptives. Full article
(This article belongs to the Special Issue Pharmacy Practice for Women’s/Reproductive Health)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-3
Back to TopTop